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Background. An epidemic of end-stage renal disease (ESRD) is
accompanying the rising rates of hypertension, type 2 diabetes and
cardiovascular disease among Aborigines in the Northern Terri-
tory of Australia. Incidence rates are now 21 times those of
nonAboriginal Australians and are doubling every four years. We
describe the rates and associations of renal disease in one remote
community, which has a current ESRD incidence of 2700 per
million, and cardiovascular mortality among the highest in Aus-
tralia.
Methods. Between 1992 and 1995 a community-wide screening
program was conducted, in which the urinary albumin/creatinine
ratio (ACR) was used as the chief renal disease marker. More
than 90% of the population ages five and older participated.
Results. Albuminuria was evident in early childhood and in-
creased dramatically with age; 26% of adults had microalbumin-
uria and 24% had overt albuminuria. All renal failure developed
out of a background of overt albuminuria. ACR was significantly
correlated with the presence of scabies at screening, with a history
of poststreptococcal glomerulonephritis, which is epidemic and
endemic in the community, with increasing body wt, blood pres-
sure, glucose, insulin and lipid levels, and with evidence of heavy
drinking. ACR was also significantly and inversely correlated with
birth weight. As a result of its association with deteriorating
hemodynamic and metabolic profiles, increasing ACR was also
correlated with increasing cardiovascular risk score. Direct obser-
vations showed, and multivariate models predicted, progressive
amplification of ACR when multiple risk factors were present
simultaneously. Albuminuria also clustered in families.
Conclusion. Renal disease in this population is multifactorial,
with risk factors related to whole-of-life nutrition, metabolic and
hemodynamic profiles, infections, health behaviors, and possibly a
family predisposition. Its relationship to low birth weight, and its
associations with deteriorating metabolic and hemodynamic pro-
files, suggest that renal disease is, in part, a component of
Syndrome X, which explains the simultaneous increase in meta-
bolic, cardiovascular and renal disease in Aboriginal people. The
family clustering might have both environmental and genetic
causes, and is under further investigation. Most of the identified
risk factors arise out of poverty, disadvantage and accelerated
lifestyle change, and the current epidemic can be explained by the
confluence of many risk factors in the last few decades. The
introduction of effective and sustained programs to address social,
economic and educational inequities in all Aboriginal communi-
ties, and of screening and renal- and cardiovascular-protective
treatment programs for those already afflicted are matters of
great urgency.
The health of Aboriginal people in the Northern Terri-
tory (NT) of Australia is among the worst in the world, with
persisting low birth weights and serious infant malnutrition,
repeated and persistent infections, and changes in diet,
exercise and health behaviors related to “Westernization.”
Body weight, hypertension, type 2 diabetes, cardiovascular
disease and renal disease are increasing rapidly. Between
1978 and 1991 standardized mortality rates (SMRs) for
Aboriginal adults from cardiovascular disease, diabetes and
renal disease were respectively about 5, 12 and 20 times
those of non-Aboriginal people. Over the 1980s, SMRs for
Aboriginal males increased, while deaths from ischemic
heart disease and diabetes in females actually tripled. The
aggregate incidence of treated end-stage renal disease
(ESRD) among Aboriginal people in the “Top End” of the
Northern Territory rose from 167 per million (pm) between
1985 to 1988, to 925 pm in 1996, and is doubling every four
years [1–5]. Rates vary among different groups, but all show
the same trends, and the incidence currently exceeds 1000
pm in at least five different regions [1–5].
We investigated the rates and associations of the renal
disease underlying this epidemic of renal failure in one
remote Aboriginal community.
METHODS
Between 1992 and 1995 we screened volunteers from an
isolated Northern Territory (NT) Aboriginal island com-
munity. These people have a current ESRD incidence rate
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of 2700 per million and share with another NT Aboriginal
group the highest adult mortality rates in Australia [1, 2, 6].
The 1991 census counted 957 people in this community,
with 50% less than 20 years of age [7]. In the screen, we
measured weight and height in children, examined skin for
sores and scabies, and, for people aged 101 years, mea-
sured blood pressure and serum creatinine. The adult
screen also included questions about smoking and drinking,
measurement of fasting glucose, insulin (total immunore-
active insulin, mU/liter; Pharmacia Assay Kit, Ryde, NSW,
Australia), lipids and serum gamma glutamyl transferase
(gGT) levels. Glucose tolerance, defined by WHO stan-
dards [8], was evaluated by a 75 g oral glucose challenge in
persons not known to be diabetic. In all participants, a
random urine specimen, remote from menstrual periods in
females, was tested by dipstick, avoiding samples positive
for leukocytes or nitrites until urinary infections or sexually
transmitted diseases had been excluded. The albumin/
creatinine ratio (ACR) on a single random urine specimen
was used as the renal disease marker, with albumin levels
measured by the Beckman immunoassay (Beckman Instru-
ments, Brea, CA, USA), and adjusted for simultaneous
creatinine concentrations to control for variations in uri-
nary concentration and dilution [9–15]. The following ACR
categories in g/mol, (and their US equivalents in mg/gm)
were employed: (a) ACR1, , 1.1, (95th percentile by lab
standards, or ,12 mg/g) normal; (b) ACR2, 1.1 to 3.3 (12
to 29 mg/g), suspicious; (c) ACR3, 3.4 to 33, (30 to 299
mg/g) microalbuminuria, and (d) ACR4, $ 34 ($300
mg/g), overt albuminuria [16–19]. Results of women
screened during pregnancy or within six months of delivery
were excluded from the analysis. The 18 people living away
from the community for chronic dialysis treatment could
not be included in the survey.
Birth weights of participants, recorded in clinic charts
sporadically after 1958, and consistently by the mid 1960s,
were noted. Records were also reviewed for a history of
poststreptococcal glomerulonephritis (PSGN) for persons
under 30 years at screening; records on older persons were
less complete. A positive PSGN history ultimately relied on
a diagnosis by the health care provider at the time, but
always involved a combination of hematuria and protein-
uria with recent skin sores, often with edema and increased
blood pressures; anti-DNAase titers were high in most, and
complement levels, when tested, were low.
A cardiovascular risk factor score, range 0 to 5, was
compiled for adults by allocating the value of one to each of
the five following features when present at screening [20]:
(1) overweight (BMI . 25 kg/m2); (2) hypertension (SBP $
140 or DBP $ 90); (3) high cholesterol levels (.5.5
mmol/liter); (4) high triglycerides (.1.8 mmol/liter) or low
high density lipoprotein (HDL) cholesterol levels (,0.9
mmol/liter in females and ,1.0 mmol/liter in males); and
(5) high fasting glucose levels (.5.4 mmol/liter).
Information was analyzed with the STATA and Splus 4
statistical packages [21, 22]. Variables with skewed distri-
butions were described by the median or geometric mean
and 95% confidence intervals. Multivariate linear regres-
sion was used to evaluate correlation of logACR (to
normalize the distribution) with other variables, and odds
ratios (OR) and 95% confidence intervals (CI) for elevated
ACR by category were calculated by multivariate logistic
regression.
RESULTS
Results were obtained on 382 children aged 5 to 17 years
and on 487 adults (181 years old), representing 100% and
89% of the respective census populations. Their general
health was poor. The average children’s weight was at the
25th percentile, 67% had skin sores, and 33% had scabies;
80% had chronic middle ear disease, many had mucopuru-
lent nasal discharge and 10% had a productive cough. As
reported elsewhere [23], 75% of adults smoked, and 25% of
women and 85% of men drank, with most males drinking to
excess. Twenty percent of adults had skin sores and 15%
had scabies; 33% were overweight (BMI .25 kg/m2), 24%
had hypertension (SBP $ 140 or DBP $ 90 mm Hg, most
untreated), 41% had elevated fasting triglyceride levels
(.1.8 mmol/liter) and 17% had elevated cholesterol levels
(.5.4 mmol/liter); 19% had diabetes and 12% had im-
paired glucose tolerance, and 26% had a high gGT (.40
U/liter for women, .60 U/liter for men), which segregated
strongly (4-fold) among drinkers. Fungal skin infections,
otitis media and externa, productive cough, chronic ob-
structive lung disease, gingivitis and loss of teeth were all
very common.
Episodes of PSGN had been recorded for 120 of 423
(28.4%) people less than 30 years old. Eighty-six percent of
PSGN episodes had occurred before 10 years of age, and
108 episodes (90%) had occurred more than four years
before screening. Seventy-five of these episodes occurred
during four epidemics, and 45 cases were sporadic.
Birth weights were available for 618 people who were 5
to 37 years old at screening. Mean birth weight was 2.795 6
0.5 kg; it rose from 2.64 6 0.49 kg for those born in 1955 to
1964, to 2.94 6 0.48 kg for those born in 1985 to 1988.
Overall 27.6% had been low birth weight babies (,2.5 kg).
Gestational age could not be accurately estimated for most;















5–9 114 0.7 (0.65–0.76) 80% 15% 4% 1%
10–19 291 0.7 (0.60–0.74 74% 17% 8% 1%
20–29 190 1.3 (0.9–1.7) 48% 20% 22% 11%
30–39 128 4.3 (2–80 29% 20% 30% 22%
40–49 86 16 (5–26 16% 19% 28% 37%
501 60 30 (16–46) 3% 12% 38% 47%
chi square 314, df 5 15, P , 0.001
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however, as is in other developing societies, most under-
weight Aboriginal babies in the NT, and 70% from a recent
study, are “small for dates” [24–26].
Table 1 shows the dramatic increase in ACR with
increasing age. More than 20% of the youngest children
had elevated ACR, and half the adults, and 84% of those of
501 years had either micro- or overt albuminuria. ACRs
were slightly higher in females up to age 30 years, and
higher in males after 30 years of age.
Figure 1 shows that hematuria, detected in 25.5% of
participants overall, was more common in those with micro-
or overt albuminuria, but was also present in a substantial
proportion of persons with normal ACRs. Rates of hyper-
tension rose with increasing ACR category. Finally, people
with elevated serum creatinine levels were segregated
powerfully in the highest ACR category.
As recognized previously [27], some families are at
special risk for renal disease and albuminuria. Figure 2
Fig. 1. Frequency of hematuria (A), hypertension (B), and elevated serum creatinine (C) by the albumin/creatinine ratio (ACR) category. The ACR
categories are defined in the Medods section. In A, hypertension was defined as $ small by dipstick. In B, hypertension was defined as SBP $ 140 and
DBP $ 90 mm Hg. In C, elevated serum creatinine was defined as . 106 mmol/liter for females and . 120 mmol/liter for males. P 5 0 for all three
groups.
Fig. 2. Family clustering of renal disease.
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shows one (of many) such families. However, every com-
munity member had a first or second degree relative with
some degree of renal disease. ACR also correlated signif-
icantly with several factors evaluated in the health screen.
In children of 5 to 17 years ACR correlated significantly
with scabies at time of screening, with a history of PSGN,
and inversely with birth weight. In adults (181 years), ACR
was significantly correlated with the presence of scabies at
screening, and with a history of PSGN. It was also corre-
lated with weight, BMI, waist and hip measurements, with
increasing blood pressure, with fasting levels of cholesterol,
triglycerides, glucose, insulin and gGT, and with rates of
diabetes. ACR in adults was also correlated inversely and
significantly with birth weight. There was no increase in
albuminuria among smokers. Table 2 shows how these
characteristics changed with increasing ACR category. As a
result of its correlation with deteriorating blood pressure
and metabolic profiles, increasing ACR category was also
correlated with increasing cardiovascular risk score.
Table 3 shows the estimated strength of some of these
associations. In children the likelihood of albuminuria was
almost doubled in the presence of scabies; it was also
increased in low birth weight children, but the association
did not achieve significance. A PSGN history was associ-
ated with a fourfold increase in the likelihood of microalbu-
minuria in persons of 10 to 29 years. In adults, the risk
enhancement associated with all the cited factors was
strong, and weight, hypertension, high cholesterol levels,
high triglyceride levels, scabies, and diabetes, retained
independent significance in the final model.
Figures 3 to 7 demonstrate some of these correlations.
Figure 3 shows the increased frequency of overt albumin-
uria in adults of low birth weight; this effect is described in
more detail elsewhere [28]. Figure 4 shows the pronounced
effect of a history of PSGN on microalbuminuria. Figure 5
shows the higher rates of albuminuria in adults with scabies
present at time of screening. Figure 6 shows the correlation
of hypertriglyceridemia with albuminuria. This correlation
was observed in drinkers and nondrinkers, and in persons
with normal glucose tolerance as well as the aggregate
group. Figure 7 shows the marked increase in overt albu-
minuria at every age in persons with diabetes.
Figure 8 to 10 illustrate the successive amplification of
albuminuria in the presence of more than one risk factor.
Figure 8 demonstrates the combined effects of BMI and
birth weight in adults. Those with higher BMIs (above the
adult median) had higher rates of albuminuria than those
of lower BMIs, and low birth weight amplified risk in both
categories. Overt albuminuria was least frequent in persons
of normal birth weights and lower BMIs, and most common
in low birth weight persons of higher BMIs. Figure 9 shows
Table 2. Clinical features that change with increasing albumin/creatine ratio (ACR) category
ACR1 ACR21
Children 5–17 years old
With scabies (of 298 person) 26% 39%
Birth weight, kg (of 320) 2.91 6 0.51 2.73 6 0.49
Birth weight ,2.5 kg 21% 28%
ACR1 ACR2 ACR3 ACR4
Persons 5–29 years old
With a history of PSGN (of 423 persons) 25% 20% 58% 54%
Adults 181 years old
With scabies (of 373 persons) 7% 14% 12% 31%
Birth weight, kg persons ,38 years (of 250) 2.71 6 0.47 2.75 6 0.48 2.73 6 0.48 2.54 6 0.46
Birth weight ,2.5 kg, persons ,38 years 31% 34% 31% 52%
Weight, kg (of 488) 60 6 14 63 6 14 68 6 15 71 6 18
Waist, cm (of 486) 82 6 12 87 6 13 91 6 13 97 6 13
Hips, cm (of 486) 87 6 13 90 6 13 95 6 13 98 6 14
BMI, kg/m2 (of 488) 22 6 5 23 6 5 24 6 5 26 6 5
Systolic BP, mm Hg, (of 484) 117 6 15 118 6 18 125 6 16 131 6 20
Diastolic BP, mm Hg (of 484) 69 6 12 73 6 12 76 6 13 83 6 16
Fasting triglycerides, mmol/liter (of 407) 1.7 6 1.0 1.8 6 1.4 2.1 6 1.4 3.2 6 3.3
Fasting LDL, cholesterol, mmol/liter (of 409) 3.2 6 0.9 3.6 6 1.2 3.6 6 1.1 4.3 6 1.3
Gamma glutamyl transferase, U/liter (of 468) 35 6 27 43 6 39 54 6 50 60 6 63
Fasting insulin, mU/liter (of 379) 6.2 (5.1–7.0) 6.7 (5.5–8.2) 8.6 (7.3–9.8) 9.4 (7.7–10.7)
Fasting glucose, mmol/liter (of 428) 4.5 6 0.7 4.8 6 1.2 5.5 6 2.5 6.3 6 3.1
2 hour insulin, mU/liter (of 336)a 26 (22–31) 28 (24–37) 42 (31–50) 44 (34–55)
2 hour glucose, mmol/liter (of 358)a 5.8 6 1.5 6.2 6 2.1 7.1 6 3.5 7.7 6 3.6
Diabetes (of 404) 4% 9% 17% 43%
Cardiovascular risk score $3 (of 402) 10% 13% 30% 52%
Data are mean 6 SD, or median (95% CI), or percentages.
a Excludes known diabetics
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the additive effects of higher BMIs and scabies on albu-
minuria in adults. Finally, Figure 10 shows the predicted
amplification of albuminuria produced by the simultaneous
operation of risk factors that retained significance in the
final adult multivariate model.
DISCUSSION
The extraordinary prevalence of albuminuria in this
community is compatible with their high rates of serious
renal disease and renal failure. Nonetheless it understates
the full impact of renal disease on the community, due to a
survival bias against persons with albuminuria and inability
to include dialysis patients with terminal renal disease in
the study. The presence of albuminuria, although subtle, in
the youngest children, and its increase with age, provide
strong circumstantial evidence for the progression of renal
disease from early in life. Hematuria, however, is probably
of nonrenal as well as renal origin, and in the absence of
significant albuminuria is unlikely to mark serious renal
disease [29, 30].
Albuminuria is associated with skin infections and their
sequelae, with low birth weight, with increasing adolescent
and adult weight, increasing blood pressure, dyslipidemia,
insulin resistance and glycemia, of which diabetes consti-
tutes only a variable and advanced manifestation, and
probably with excessive drinking. Thus, renal disease in this
community, and in individuals within the community, is
multidimensional. The extraordinary rates of disease are
potentially explained by the multitude of risk factors, their
high prevalence, and the amplification of renal damage
through their interaction. A confluence of crucial events in
the last five decades has probably produced the current
epidemic, such as abandonment of hunter-gatherer/no-
madic ways, settlement in crowded, substandard and dirty
houses, poor hygiene, increases in body fat due to a
Westernized diet of poor quality and lack of exercise, abuse
of alcohol (legalized in this community in 1967), and, as
outlined below, improved survival of low birth weight
infants. Renal disease in other Aboriginal people probably
has similar causes [14, 13]. The pattern and basis of family
clustering is still to be illuminated; it might be based on
environmental and/or genetic factors, which are matters for
further analysis. However, with albuminuria present in
most adults in the community, and in nearly all those who
Table 3. Enhancement of risk for elevated albumin/creatinine ratio (ACR)
Risk factors







Children 5–17 years Birth weight, per kg reduction 1.9 (1.2–3.2) 1.8 (1.1–3.1) 1.7 (.95–2.9)
Scabies 1.7 (0.9–2.8) 1.8 (1.1–3.1) 1.8 (1.1–3.1)
Risk factors







Children 5–17 years PSGN history 5.5 (2.4–12.6) 4.5 (1.9–10.5) 4.8 (2.0–11.5)
Adults 18–29 years PSGN history 3.3 (1.8–9.2) 3.5(1.1–11.5) 3.1 (1.0–10.4)







Adults 18–37 years Birth weight, per kg reduction 1.8 (0.5–4.0) 1.6 (0.8–3.6) 3.0 (1.2–7.2)
Adults 181 years Scabies 3.2 (1.8–5.8) 2.8 (1.5–5.4) 2.2 (1.1–4.6)
BMI .25 kg/m2 2.7 (1.7–4.1) 2.8 (1.7–4.4) 1.8 (1.0–3.0)
SBP $ 140 or DBP $ 90 mm Hg 5.2 (3.2–8.2) 4.7 (2.8–8.0) 3.5 (1.9–6.2)
Cholesterol .5.5 mmol/liter 3.6 (2.1–6.0) 3.1 (1.8–5.5) 2.2 (1.2–4.2)
Triglycerides . 1.8 mmol/liter 3.5 (2.2–5.7) 2.7 (1.7–4.5) 1.7 (1.0–3.0)
Diabetes 6.0 (3.5–10.4) 3.8 (2.1–6.9) 2.1 (1.1–4.0)
Fasting insulin .10.1 mU/liter 1.8 (1.1–3.0) 1.7 (1.0–3.0) —
Fasting glucose .5.4 mmol/liter 4.5 (2.6–7.7) 2.8 (1.5–5.0) —
High gamma GTd 2.2 (1.4–3.5) 1.8 (1.1–3.0) —
Impaired glucose tolerance 2.5 (1.3–5.0) 1.7 (0.8–3.5) —
Abbreviations are in the Appendix.
a Adjusted for age, sex and weight for age
b Adjusted for age, sex, weight, birth weight, and, in adults, blood pressure.
c Adjusted for age, sex, weight, blood pressure for birth weight cohort, and adjusted for age, sex, and factors that retained significance in the final
model in the aggregate adult population
d .40 m/liter for women, .60 U/liter for men
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survive to middle age, any family predisposition is clearly a
matter of degree.
Decreasing birth weight correlates with albuminuria
from childhood, and its link with overt albuminuria by early
adult life confirms its ultimate relationship to renal failure
[31]. Thus, intrauterine malnutrition and/or other causes of
low birth weight confer susceptibility to progressive renal
disease. This complements the relationship of low birth
weight to cardiovascular disease, hypertension, type 2 dia-
betes and dyslipidemia, collectively termed Syndrome X,
reported in other populations [32, 33]. The predisposition
to renal disease might be mediated through reduced
Fig. 3. Birth weight and albumin/creatinine ratio (ACR) in adults.
Symbols are: (M) birth weight $ 2.5 kg; u birth weight , 2.5 kg.
Fig. 4. History of poststreptococcal glomerulonephritis (PSGN) and
albumin/creatinine ratio (ACR) in different age groups. Symbols are: (M)
No PSGN; (u) PSGN.
Fig. 5. Scabies and albumin/creatinine ratio (ACR) in adults. Symbols
are: (M) no scabies; (u) scabies.
Fig. 6. High triglycerides and albumin/creatinine ratio (ACR) in adults.
Symbols are: (M) # 1.8 mmol/liter triglycerides; (u) . 1.8 mmol/liter
triglycerides.
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nephron endowment related to intrauterine malnutrition
[34, 35], which accelerates renal obsolescence that accom-
panies ageing and the multiple renal insults encountered
throughout postnatal life. In our young adults we could find
no association between low birth weight and increased
blood pressure, impaired glucose tolerance or diabetes to
explain its relationship to renal disease indirectly. Ironi-
cally, the current chronic disease epidemic is probably the
legacy, in part, of the dramatic fall in infant mortality
between the late 1950s and late 1970s (from perhaps 140 to
160/1000 to 30/1000) due to better hospital management of
sick babies [36]. With most of the prior excess mortality and
subsequent retrieval among low birth weight infants, a large
cohort of persons has now survived to adult life at high risk
Fig. 7. Diabetes and albumin/creatinine ratio (ACR) in adults. Symbols
are: (M) no diabetes; (u) diabetes.
Fig. 8. Effects of body mass index (BMI) and birth weight on the
albumin/creatinine ratio (ACR) in adults. Symbols are: (M) birth
weight $ 2.5 kg; (u) birth weight , 2.5 kg.
Fig. 9. Amplification effects of body mass index (BMI) and scabies on
the albumin/creatinine ratio (ACR) in adults. Symbols are: (M) BMI ,
23.3, no scabies; (u) BMI $ 23.3, no scabies; (f) BMI $ 23.3 plus scabies.
Fig. 10. Predicted amplification of the albumin/creatinine ratio (ACR)
by the operation of multiple risk factors in adults.
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for renal and other “lifestyle” diseases. The gradual in-
crease in birth weights in this community that continues to
the present is grounds for some optimism.
The correlations of albuminuria with the features of
Syndrome X, and their shared links with low birth weight
suggest that renal disease is, at least in part, a component
of that syndrome. This explains the simultaneous rise in
cardiovascular disease and renal disease in Aboriginal
people, and the link between albuminuria and cardiovas-
cular disease documented in many populations [37–43].
The extraordinary rates of PSGN in this community are
compatible with the high rates of skin disease and heavy
colonization with group A streptococci with constantly
changing sero-types [44, 45]. A (mostly remote) history of
PSGN is, in turn, associated with albuminuria. Other
reports of subtle evidence of ongoing disease in persons
remote from their PSGN episodes support this association
[46–48]. High rates of albuminuria have also been noted in
persons with scabies and skin sores in other populations
[49]; these lesions might mark persons likely to develop
PSGN, but, like other persistent infections, they might also
mediate renal injury more directly through inflammatory
mediators and growth factors [50–52].
Renal biopsies in this community (N 5 88) show the
usual spectrum of changes, and incidentally with features of
diabetic nephropathy in only 28% of diabetics. The single
consistent finding, in isolation, or in conjunction with other
changes, is marked glomerular enlargement, with variable
degrees of segmental and global sclerosis [53–55]. Trophic
effects of Syndrome X, chronic infection, and compensa-
tory hypertrophy due to reduced nephron endowment
might contribute to such glomerulomegaly, which has also
been noted in other Australian Aborigines, US Blacks,
American Indians and Hispanic people, all at high risk for
renal disease [55–57].
Current renal disease classifications do not accommo-
date a multidimensional perspective. More practical sys-
tems might incorporate epidemiologic observations, ac-
knowledge the limitations of morphology in defining
etiology, recognize the operation and interaction of patho-
physiological factors over a continuum, and further explore
relationships between renal disease and other common
conditions.
All the environmental and clinical risk factors identified
in this study are features of poverty, disadvantage, and
accelerated lifestyle change [58], and all are amenable to
modification and prevention. The introduction of coherent,
effective and sustained programs into all Aboriginal com-
munities to address these basic issues is of immediate
urgency. We must also implement systematic screening and
treatment programs to identify people with early renal
disease and its risk factors, and prevent or arrest its
progression to renal insufficiency [59]. Morbidity and mor-
tality from diabetes and cardiovascular disease will thereby
be reduced as well.
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